Clinical Trial Update: EPO906 Therapy in Patients With Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of EPO906 for advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• EPO906

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Colorectal Neoplasms, Colonic Neoplasms | Phase 2 | Status: COMPLETED